Active	Status	Sponsor type	Region	Phase	Filter
14 Active 1 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yetman, Angela
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
Wagner, Jonathan B
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
Smith, Cynthia
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
Dallas, Lexie
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
NCT05493709: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects with Central Precocious Puberty	Recruiting	3	93	US, RoW	Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide	Foresee Pharmaceuticals Co., Ltd., QPS Holdings LLC, Changchun GeneScience Pharmaceutical Co., Ltd.	Puberty; Precocious, Central	11/25	06/26
Collins, Michelle
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
Vranicar, Mark
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
Decker, Jamie
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25